Table 4.

Serum Ig Levels in JAK3-Deficient Patients Post-BMT

Patient Age at Evaluation YrIgGIgAIgMIgE
mg/dL IU/mL
2  8.5  389 17  127  39  
  (600-1,500) (50-200)  (50-200)  (0-200)  
3  1.4  569  12 105  1  
  (400-1,300)  (20-230) (30-120)  (0-30)   
5  23.5  586  168  145 5,985  
  (600-1,500)  (50-200) (50-200)  (0-200) 
Patient Age at Evaluation YrIgGIgAIgMIgE
mg/dL IU/mL
2  8.5  389 17  127  39  
  (600-1,500) (50-200)  (50-200)  (0-200)  
3  1.4  569  12 105  1  
  (400-1,300)  (20-230) (30-120)  (0-30)   
5  23.5  586  168  145 5,985  
  (600-1,500)  (50-200) (50-200)  (0-200) 

Serum Ig levels were assessed in the three patients who were not receiving gamma globulin replacement. IgG, A, and M were measured by radial immunodiffusion, and IgE by fluoroenzymatic immuno assay. Normal values for each age are indicated in brackets parentheses.

or Create an Account

Close Modal
Close Modal